-
2621
In Vivo Tracking of Systemically Administered Allogeneic Bone Marrow Mesenchymal Stem Cells in Normal Rats through Bioluminescence Imaging
Published 2016-01-01“…Recently, mesenchymal stem cells (MSCs) are increasingly used as a panacea for multiple types of disease short of effective treatment. Dozens of clinical trials published demonstrated strikingly positive therapeutic effects of MSCs. …”
Get full text
Article -
2622
Targeting Apoptosis Pathways in Cancer with Alantolactone and Isoalantolactone
Published 2013-01-01“…This review suggests that alantolactone and isoalantolactone are potential promising anticancer candidates, but additional studies and clinical trials are required to determine their specific intracellular sites of actions and derivative targets in order to fully understand the mechanisms of therapeutic effects to further validate in cancer chemotherapy.…”
Get full text
Article -
2623
The Prospects for the Therapeutic Implications of Genetically Engineered Probiotics
Published 2020-01-01“…The interest in the therapeutic use of probiotic microorganisms has been increased during the last decade although the doubts have ascended about the probiotics mainly because their beneficial effects are not fully understood, and, in many cases, their usefulness has not been validated in clinical trials. Consequently, the notion got a considerable interest in those strains having proven probiotic potential to be engineered for improvement in their beneficial features. …”
Get full text
Article -
2624
Combined Effect of Lentinan and Cisplatin on Cytokines IL-6, TNF-α, and TGF-β in Tumor Therapy
Published 2019-01-01“…Many cytokines have shown positive effect on different malignancies in clinical trials. Studies have shown that such cytokines as IL6, TNF-α, and TGF-β play a quite important role in the formation of tumor microenvironment. …”
Get full text
Article -
2625
Targeting the kynurenine pathway: another therapeutic opportunity in the metabolic crosstalk between cancer and immune cells
Published 2025-01-01“…Insights from preclinical studies, recent clinical trials, and promising therapeutic combinations will be discussed to elucidate and promote a clear path forward for the direction of KP research into cancer-related outcomes.…”
Get full text
Article -
2626
Intravenous γ Globulin for Intractable Abdominal Pain due to IgA Vasculitis
Published 2020-01-01“…Given the toxicity and/or need for long-term administration of other second-line immunosuppressive therapies in corticosteroid-resistant IgA vasculitis, such as rituximab, cyclosporine, cyclophosphamide, azathioprine, or colchicine, we propose that IVIg may be a useful and safe treatment option, although randomized controlled clinical trials are needed in order to clarify its role in the treatment of abdominal pain in IgA vasculitis.…”
Get full text
Article -
2627
Cancer Vaccine by Fusions of Dendritic and Cancer Cells
Published 2009-01-01“…In the human studies, T cells stimulated by DC/tumor fusion cells are effective in lysis of tumor cells that are used as the fusion partner. In the clinical trials, clinical and immunological responses were observed in patients with advanced stage of malignant tumors after being vaccinated with DC/tumor fusion cells, although the antitumor effect is not as vigorous as in the animal tumor models. …”
Get full text
Article -
2628
Stem cells in Osteoporosis: From Biology to New Therapeutic Approaches
Published 2019-01-01“…This review is focused on the current views regarding the implication of the stem cells in the cellular and physiologic mechanisms of osteoporosis and discusses data obtained from stem cell-based therapies of osteoporosis in experimental animal models and the possibility of their future application in clinical trials.…”
Get full text
Article -
2629
Long COVID and gut microbiome: insights into pathogenesis and therapeutics
Published 2025-12-01“…Altered gut microbiome has been proposed as one of the plausible mechanisms involved in the pathogenesis of PACS; extensive studies have emerged to bridge the gap between the persistent symptoms and the dysbiosis of gut microbiome. Recent clinical trials have indicated that gut microbiome modulation using probiotics, prebiotics, and fecal microbiota transplantation (FMT) led to improvements in multiple symptoms related to PACS, including fatigue, memory loss, difficulty in concentration, gastrointestinal upset, and disturbances in sleep and mood. …”
Get full text
Article -
2630
Herbal Medicinal Products from Passiflora for Anxiety: An Unexploited Potential
Published 2020-01-01“…The results showed that Passiflora species have health benefits but clinical trials are still scarce. The complexity of Passiflora extracts creates challenges for the development of herbal medicines. …”
Get full text
Article -
2631
Real-Time Fall Risk Assessment Using Functional Reach Test
Published 2017-01-01“…Preliminary performance will be presented to justify the further exploration of the FRT function in mStroke through clinical trials on individuals after stroke, which may guide its ubiquitous exploitation in the near future.…”
Get full text
Article -
2632
Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells
Published 2016-01-01“…Islet transplantation to portal vein provides an approach to compensate for loss of insulin producing cells. Clinical trials demonstrated that even partial islet graft function reduces severe hypoglycemic events in patients. …”
Get full text
Article -
2633
GH Therapy in Non–Growth Hormone-Deficient Children
Published 2024-12-01“…Recently, long-acting formulations of rhGH have been approved and licensed for GHD, and clinical trials are ongoing for other conditions. In this paper, we review the rhGH therapy in children with conditions other than GHD.…”
Get full text
Article -
2634
An Anaplastic Lymphoma Kinase-positive Inflammatory Myofibroblastic Tumor with Rapidly Acquired Resistance to First-line Anaplastic Lymphoma Kinase Inhibitor: A Case and Literature...
Published 2024-01-01“…Approximately half of IMTs are positive for an anaplastic lymphoma kinase (ALK) gene rearrangement which causes aberrant expression. Early phase clinical trials have demonstrated the efficacy of ALK inhibitors in the treatment of IMTs. …”
Get full text
Article -
2635
Unlocking the therapeutic potential of microalgal astaxanthin a super antioxidant in oral cancer and associated ailments
Published 2024-06-01“…Therefore, future research should aim at refining dosage strategies, investigating delivery mechanisms, and executing comprehensive clinical trials to validate its efficacy. Astaxanthin emerges as a game-changer in oral health, poised to enhance outcomes and alleviate suffering in oral diseases.…”
Get full text
Article -
2636
AM3, an Oral BRM: Protective Agent against Iatrogenic Bone-Marrow and Liver Damage in Breast Cancer Patients under Conventional Adjuvant Radiochemotherapy
Published 1992-01-01“…In five clinical trials AM3, a polysaccharide/protein biological response modifier, was given (3 g/day; two capsules, tid) to 79 breast cancer patients undergoing adjuvant radio- and/or chemotherapies. …”
Get full text
Article -
2637
Challenges in Initiating Antiretroviral Therapy in 2010
Published 2010-01-01“…Many clinical trials have shown that initiating antiretroviral therapy (ART) at higher rather than lower CD4 T cell-positive counts results in survival benefit. …”
Get full text
Article -
2638
Balancing Treatment Allocation over Continuous Covariates: A New Imbalance Measure for Minimization
Published 2012-01-01“…In many clinical trials, it is important to balance treatment allocation over covariates. …”
Get full text
Article -
2639
New insights into anti-depression effects of bioactive phytochemicals
Published 2025-02-01“…In this literature review, we describe the pharmacological actions, experimental models, and clinical trials of the antidepressant effects of various phytochemicals. …”
Get full text
Article -
2640
MDMA Impairs Response to Water Intake in Healthy Volunteers
Published 2016-01-01“…Thus, hyponatremia appears to be a significant risk when hypotonic fluids are consumed during MDMA use. Clinical trials and events where MDMA use is common should anticipate and mitigate this risk.…”
Get full text
Article